Evaluation shows that adding T2-FLAIR to T1w imaging significantly enhances amyloid PET prediction in Alzheimer’s patients.
Motivation: Accurate amyloid-beta positivity prediction is essential for identifying patients for Alzheimer's disease trials and treatments, and T1w only MRI-based predictions have showed moderate performance. Goal(s): To evaluate whether adding T2-FLAIR to T1w imaging enhances deep learning model performance for predicting amyloid PET positivity. Approach: Two EfficientNet models were trained on 4,058 multi-contrast MRI exams and validated using internal and external test sets, with statistical comparison of T1w-only and T1w+T2-FLAIR inputs. Results: The T1w+T2-FLAIR model significantly improved PET-based amyloid status prediction, showing robustness across internal and external test sets. Activation maps highlighted brain regions, particularly around ventricles, linked to white matter abnormalities. Impact: Adding T2-FLAIR to T1w MRI in deep learning models significantly improves amyloid PET positivity prediction, aiding early Alzheimer's disease detection. This approach enhances non-invasive opportunistic screening, potentially streamlining patient selection for clinical trials and targeted treatments.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: